IGF-I Antibodies

Santa Cruz Biotechnology delivers a wide array of IGF-I monoclonal antibodies for research focused on understanding Insulin-like Growth Factor I (IGF-I) in various biological processes. IGF-I monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IGF-I is a crucial peptide hormone that plays a significant role in growth and development, particularly in muscle and bone tissue. IGF-I functions in cellular growth, differentiation, and survival, making it an important factor in various physiological and pathological conditions, including growth disorders and cancer. Understanding IGF-I mechanisms has become increasingly important for research in endocrinology and oncology. IGF-I research continues to reveal new insights into cellular signaling pathways and potential therapeutic targets. IGF-I monoclonal antibodies enable detailed investigation of growth factor regulation and its impact on developmental processes. Santa Cruz Biotechnology monoclonal antibodies for IGF-I research support scientists worldwide in advancing our understanding of human health and disease mechanisms.